A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mirogabalin | CAS 1138245-13-2 - Request Quote

Picture of Mirogabalin
SZ CAT No:SZ-M115001
CAS No
1138245-13-2
Mol.F.
C12H19NO2
Mol.Wt.
209.3
Inv. Status
Under QC Approval
Rel. CAS No(1138245-21-2 besylate salt)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Mirogabalin is chemically 2-((1R,5S,6S)-6-(Aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid. Mirogabalin is supplied with detailed characterization data compliant with regulatory guideline. Mirogabalin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mirogabalin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1138245-13-2

Purchase 1138245-13-2

Order 1138245-13-2

Enquire 1138245-13-2

price of 1138245-13-2

1138245-13-2 Supplier

1138245-13-2 Manufacturer

1138245-13-2 Exporter

buy high quality Mirogabalin

Purchase Mirogabalin

Mirogabalin suppliers

Mirogabalin manufacturers

Mirogabalin price

Order Mirogabalin

Enquire Mirogabalin

Mirogabalin cost

Mirogabalin Supplier

Mirogabalin Distributor

Mirogabalin for Method Validation

Mirogabalin Reference Standard

Mirogabalin for ANDA Filing

Mirogabalin for Forced Degradation Studies

Mirogabalin Identification Standards

Mirogabalin for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,